Abstract
Background
The purpose of this study was to evaluate the effect of single-incision plus one port laparoscopic surgery (SILS + 1) for myomectomy.
Methods
We retrospectively analyzed data from patients who underwent laparoendoscopic single-site myomectomy (LESS-M group, n = 40) and SILS + 1 (SILS + 1-M group, n = 40) for myomectomy at our hospital from October 2018 through December 2020. The patients’ baseline demographic information and clinical data were compared between the two groups.
Results
The results showed that no significant difference in basic characteristics or between the number, size, and location of uterine myomas between the two groups (p < 0.05). However, the surgery was more difficult and the total operating time was significantly longer in the LESS-M group compared to the SILS + 1-M group (83.5 ± 14.2 vs. 108.2 ± 18.1 min, p = 0.001). Moreover, the estimated intraoperative blood loss (113.4 ± 46.5 vs. 211.4 ± 60.3 ml, p = 0.001) and changes in hemoglobin level (13.1 ± 7.6 vs. 18.2 ± 6.0, p = 0.001) were significantly lower in the SILS + 1-M group compared to the LESS-M group. In addition, no serious intraoperative or postoperative complications occurred after surgery in either group. The clinical outcomes in the SILS + 1-M group were associated with a significant reduction in total surgical time compared to the LESS-M group (p < 0.05).
Conclusion
SILS + 1 for myomectomy is popular in clinics, with a satisfactory clinical effect.
Author contributions
Conception and design of the study: Gaoli Niu, Yanhong Zhai. Study search: Hua Zhao. Interpretation of the retrieved studies: Hong Wang Drafting the article: Gaoli Niu, Yanhong Zhai. Revising the article: Lingli Zhao. All authors contributed to the article and approved the submitted version.
Consent for publication
Not applicable.
Data availability statement
The data used to support the findings of this study are available from the corresponding author upon request.
Disclosure statement
All authors have no conflicts of interest or financial ties to disclose.
Ethical approval
The study was approved by the Research Ethics Board of the First Affiliated Hospital of Henan Polytechnic University [KY2021-04-025].